CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.Other objectives are to determine pharmacokineti...
Phase 3
Barcelona, Spain and 58 other locations
known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...
Phase 2, Phase 3
Barcelona, Spain and 214 other locations
OA investigational vaccine when it is co-administered with a COVID-19 messenger ribonucleic acid (mRNA) vaccine (Omicron XBB.1.5), ...
Phase 3
Barcelona, Spain and 23 other locations
This is a Phase IIb, open-label, uncontrolled, multi-centre, non-inferiority clinical trial, to assess the safety and immunogenicity of BIMERVAX® as...
Phase 2
Barcelona, Spain and 6 other locations
The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...
Phase 2
Barcelona, Catalunya, Spain and 56 other locations
The main aim of this study is to check if there are side effects from BAX 888 and to determine the dose of BAX 888 for treating severe hemophilia A i...
Phase 1, Phase 2
Barcelona, Spain and 25 other locations
The purpose of this study is to determine the clinical benefit and characterize the safety profile of tabelecleucel for the treatment of Epstein-Barr...
Phase 3
Barcelona, Spain and 70 other locations
This study will be conducted to evaluate the efficacy of lecanemab in participants with early Alzheimer's disease (EAD) by determining the superiorit...
Phase 3
Barcelona, Spain and 246 other locations
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...
Phase 3
Barcelona, Spain and 401 other locations
treatment in Study M16-067 with no final endoscopy due to the Covid-19 pandemic or due to the geopolitical conflict in Ukraine and ...
Phase 3
Barcelona, Spain and 426 other locations
Clinical trials
Research sites
Resources
Legal